Cardiovascular disease remains the leading cause of death globally, and environmental factors increasingly appear to play a role alongside traditional risk factors. PFAS exposure has been linked to elevated blood pressure, altered cholesterol profiles, and increased cardiovascular disease risk through multiple pathways.
PFAS and Hypertension
Blood pressure elevation is one of the most consistent cardiovascular findings associated with PFAS exposure. Multiple epidemiological studies have found positive associations between serum PFAS levels and both systolic and diastolic blood pressure in adults. A systematic review of 20+ studies found that higher PFAS levels were associated with approximately 2–4 mmHg increases in systolic blood pressure — a difference that, while appearing small at the individual level, has significant population-level cardiovascular implications.
Pregnant women appear particularly vulnerable, with several studies finding that PFAS-associated hypertension during pregnancy manifests as preeclampsia — a dangerous complication affecting both maternal and fetal outcomes. The mechanisms may involve PFAS effects on endothelial function, kidney sodium handling, and vascular tone regulation.
Cholesterol Elevation: The Most Consistent Finding
Among all PFAS cardiovascular effects, the association with elevated total cholesterol and LDL cholesterol is the most robustly replicated finding in the literature. This relationship has been confirmed in studies across dozens of countries, in children and adults, in highly exposed communities and general population samples.
A meta-analysis quantifying the cholesterol effect found that each doubling of serum PFOA was associated with approximately 5–8 mg/dL higher total cholesterol. Given that the general population experiences chronic low-level PFAS exposure throughout life, the cumulative cholesterol-raising effect could be substantial at the population level.
Atherosclerosis and Coronary Artery Disease
Some studies have directly examined whether PFAS promote atherosclerosis — the arterial plaque buildup that underlies most heart attacks and strokes. Carotid intima-media thickness (CIMT), a surrogate marker for atherosclerosis, has been found to be greater in adults with higher PFAS exposure in several studies.
A prospective study from China found that higher PFAS levels were associated with significantly increased risk of cardiovascular events over a 10-year follow-up period. While more longitudinal data are needed to confirm causal relationships, the consistency of cross-sectional findings and plausible mechanisms support PFAS as a cardiovascular risk factor.
Reducing Cardiovascular Risk Through PFAS Reduction
For individuals with existing cardiovascular risk factors — including elevated cholesterol, hypertension, diabetes, or family history — reducing PFAS exposure through water filtration is a practical step that complements medical management. Reverse osmosis filtration eliminates the primary dietary source of PFAS exposure, potentially helping to reduce the PFAS-associated cholesterol burden over time.
Cardiologists and primary care physicians are increasingly incorporating environmental toxicant discussions into cardiovascular risk assessments, recognizing that traditional risk factors do not fully explain individual variability in cardiovascular outcomes.